Form 4 for MRK Merck & Co.
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-08 · accession 0001127602-25-004103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 | 2025-02-08 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | F - Tax | $87.28 | -6,404 | 39.2K | -14% | -$558.9K |
| D | 2025-02-11 | 2025-02-08 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $87.28 | +13.0K | 45.6K | +40% | +$1.13M |
| D | 2025-02-11 | 2025-02-08 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-08 | F | D | 6,404 | $87.28 | 39,205.47 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-08 | M | A | 13,002 | $87.28 | 45,609.47 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-02-08 | M | D | 13,002 | $0.00 | 0 | D | — · 2025-02-08 to 2025-02-08 | 13,002 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 2/8/2025. The Reporting Person's Form 3 filed on 3/10/2022 incorrectly reported that these restricted units vested and were to be distributed in three equal installments on 2/8/2023, 2/8/2024, and 2/8/2025. |